Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Sarah L. Anderson

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2017 Dec 27; 1-10. PMID: 29260929.
      View in: PubMed
    2. Anderson SL, Kattappuram RS, Marrs JC, Joseph NM. Intentional Brodifacoum Ingestion. Am J Med. 2017 Jan; 130(1):e27-e28. PMID: 27591180.
      View in: PubMed
    3. Anderson SL, Trujillo JM. Basal Insulin Use With GLP-1 Receptor Agonists. Diabetes Spectr. 2016 Aug; 29(3):152-60. PMID: 27574369; PMCID: PMC5001217 [Available on 08/01/17].
    4. Norman JL, Anderson SL. Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexant. Nat Sci Sleep. 2016; 8:239-47. PMID: 27471419; PMCID: PMC4948724.
    5. Rhyne DN, Anderson SL, Gedde M, Borgelt LM. Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. Pharmacotherapy. 2016 05; 36(5):505-10. PMID: 26749285.
      View in: PubMed
    6. Anderson SL, Trujillo JM. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2016 Jan; 7(1):4-17. PMID: 26770666; PMCID: PMC4707429.
    7. Rhyne DN, Anderson SL. Suvorexant in insomnia: efficacy, safety and place in therapy. Ther Adv Drug Saf. 2015 Oct; 6(5):189-95. PMID: 26478806; PMCID: PMC4591519.
    8. Anderson SL. Strategies for successfully navigating the pharmacy residency interview process. Am J Health Syst Pharm. 2015 Jun 01; 72(11 Suppl 1):S33-5. PMID: 25991593.
      View in: PubMed
    9. Wobeter BR, Anderson SL, Marrs JC. Characterization of diastolic dysfunction heart failure following an acute hospitalization for heart failure in an urban, underserved population. Ther Adv Cardiovasc Dis. 2015 Oct; 9(5):267-74. PMID: 25767213.
      View in: PubMed
    10. Fosmire Rundgren EW, Anderson SL, Marrs JC. Response to comment "Evaluation of aspirin use for primary prevention in diabetic patients". Ann Pharmacother. 2015 Feb; 49(2):262-3. PMID: 25583942.
      View in: PubMed
    11. Anderson SL. Dapagliflozin efficacy and safety: a perspective review. Ther Adv Drug Saf. 2014 Dec; 5(6):242-54. PMID: 25436106; PMCID: PMC4232499.
    12. Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7. PMID: 25288823.
      View in: PubMed
    13. King WM, Saseen JJ, Anderson SL. Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014 Sep; 5(5):206-11. PMID: 25177478; PMCID: PMC4131502.
    14. Anderson SL, Vande Griend JP. Quetiapine for insomnia: A review of the literature. Am J Health Syst Pharm. 2014 Mar 01; 71(5):394-402. PMID: 24534594.
      View in: PubMed
    15. Anderson SL, Marrs JC, Vande Griend JP, Hanratty R. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag. 2013 Aug; 16(4):235-41. PMID: 23537153.
      View in: PubMed
    16. Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy. 2013 Jan; 33(1):105-11. PMID: 23307551.
      View in: PubMed
    17. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71. PMID: 22825226.
      View in: PubMed
    18. Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr; 46(4):590-8. PMID: 22433611.
      View in: PubMed
    19. Vande Griend JP, Anderson SL. Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc (2003). 2012; 52(6):e210-9. PMID: 23229983.
      View in: PubMed
    20. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9. PMID: 20371755.
      View in: PubMed
    Anderson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)